Skip to Content
Merck
All Photos(1)

Documents

G003763

HPLC Analysis of Cortocisteroids in Urine on Discovery® HS F5 after SPE using Discovery® DSC-CN

application for SPE, application for HPLC

Sign Into View Organizational & Contract Pricing


About This Item

technique(s)

HPLC: suitable
solid phase extraction (SPE): suitable

test parameters

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: human urine spiked with corticosteroids at 0.5 and 1.0 μg/mL and diluted in DI water (1:1, v/v)
SPE well plate: Discovery DSC-CN 96-well SPE, 100 mg/well (575636-U)
condition: 1 mL methanol; 1 mL DI water.
sample addition: 1 mL spiked urine
washing: 1 mL 20% methanol
elution: 1 mL methanol
eluate post-treatment: Evaporate eluate with nitrogen at 30 °C. Reconstitute in 200 μL mobile phase.
column: Discovery HS F5, 5 cm x 4.6 mm I.D., 3 μm particles (567504-U)
mobile phase: [A] methanol; [B] DI water; (40:60, A:B)
flow rate: 1.5 mL/min
column temp.: 35 °C
detector: UV, 240 nm
injection: 5 μL

suitability

application for HPLC
application for SPE

application(s)

clinical

Legal Information

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service